PMID: 8604140Mar 1, 1996Paper

The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3

Journal of Molecular Biology
Y LiK N Potter

Abstract

Essentially all cold agglutinins (CA) with red blood cell I/i specificity isolated from patients with CA disease stemming from lymphoproliferative disorders utilize the VH 4-34 (VH 4-21) gene segment. This near universality of the restricted use of a single gene segment is substantially greater than that demonstrated for other autoantibodies. The monoclonal antibody 9G4 exclusively binds VH 4-34 encoded antibodies and serves as a marker for the VH 4-34 gene segment. Previous studies form our laboratory localized the 9G4 reactive area to framework region 1 (FR1). In the present study, the relative roles of VH FR1, heavy (H) chain complementarity determining region 3 (CDRH 3) and the light (L) chain in I antigen binding were investigated. Mutants containing FR1 sequences from the other VH families, CDRH 3 exchanges, and combinatorial antibodies involving L chain interchanges were produced in the baculovirus system and tested in an I binding assay. The data indicate that FR1 of the VH 4-34 gene segment and the CDRH 3 are essential for the interaction between CA and the I antigen, with the CDRH 3 being fundamental in determining the fine specificity of antigen binding (I versus i). Mutants with substantially altered CDRH 1 and CDRH...Continue Reading

Citations

Mar 4, 1998·Annals of Neurology·G P OwensD H Gilden
Jun 15, 2016·The Journal of Experimental Medicine·Joanne H ReedChristopher C Goodnow
Nov 20, 2016·Nature Communications·Yik Andy YeungJavier Chaparro-Riggers
Jan 22, 2020·Nature Immunology·Krishna M RoskinScott D Boyd
Jan 1, 1997·International Reviews of Immunology·G J SilvermanA La Cava
Mar 21, 1998·European Journal of Haematology·E Ulvestad
Jan 6, 2005·Springer Seminars in Immunopathology·Eric C B MilnerIñaki Sanz
Mar 5, 2003·Annual Review of Immunology·Nicholas Chiorazzi, Manlio Ferrarini
Oct 11, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christopher RichardsonIgnacio Sanz
Jan 1, 1997·International Reviews of Immunology·R Domiati-Saad, P E Lipsky
Oct 26, 1999·European Journal of Haematology·E UlvestadF V Shammas
Jan 1, 1997·Lupus·F K Stevenson, G J Silverman
Nov 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A CauerhffF A Goldbaum
Aug 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·E MeffreM C Nussenzweig
Jan 29, 2000·Scandinavian Journal of Immunology·N M BhatN N Teng
Apr 7, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·David W BahlerSteven H Swerdlow
Sep 27, 2019·Immunological Reviews·Deborah L BurnettChristopher C Goodnow
Nov 10, 2000·International Journal of Cancer. Journal International Du Cancer·F FaisM Ferrarini
Nov 17, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alaitz AranburuRita Carsetti
Apr 20, 2000·Transfusion Science·K N Potter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.